138 related articles for article (PubMed ID: 24274971)
1. Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis.
Qi KK; Wu J; Wan J; Men XM; Xu ZW
Peptides; 2014 Feb; 52():11-8. PubMed ID: 24274971
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of different doses of polyethylene glycosylated porcine glucagon-like peptide-2 on ulcerative colitis in male rats.
Qi KK; Lv JJ; Wu J; Xu ZW
BMC Gastroenterol; 2017 Mar; 17(1):34. PubMed ID: 28259136
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-2-loaded microspheres as treatment for ulcerative colitis in the murine model.
Wu J; Qi K; Xu Z; Wan J
J Microencapsul; 2015; 32(6):598-607. PubMed ID: 26218715
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.
Lee SH; Lee S; Youn YS; Na DH; Chae SY; Byun Y; Lee KC
Bioconjug Chem; 2005; 16(2):377-82. PubMed ID: 15769092
[TBL] [Abstract][Full Text] [Related]
6. Effects of PEGylated porcine glucagon-like peptide-2 therapy in weaning piglets challenged with lipopolysaccharide.
Qi KK; Wu J; Xu ZW
Peptides; 2014 Aug; 58():7-13. PubMed ID: 24874708
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability.
Youn YS; Chae SY; Lee S; Jeon JE; Shin HG; Lee KC
Biochem Pharmacol; 2007 Jan; 73(1):84-93. PubMed ID: 17054919
[TBL] [Abstract][Full Text] [Related]
8. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.
El-Jamal N; Erdual E; Neunlist M; Koriche D; Dubuquoy C; Maggiotto F; Chevalier J; Berrebi D; Dubuquoy L; Boulanger E; Cortot A; Desreumaux P
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G274-85. PubMed ID: 24875097
[TBL] [Abstract][Full Text] [Related]
9. PEGylated porcine glucagon-like peptide-2 improved the intestinal digestive function and prevented inflammation of weaning piglets challenged with LPS.
Qi KK; Wu J; Deng B; Li YM; Xu ZW
Animal; 2015 Sep; 9(9):1481-9. PubMed ID: 25963800
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer.
Trivedi S; Wiber SC; El-Zimaity HM; Brubaker PL
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G840-9. PubMed ID: 22323126
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis.
L'Heureux MC; Brubaker PL
J Pharmacol Exp Ther; 2003 Jul; 306(1):347-54. PubMed ID: 12815012
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2.
Ning MM; Yang WJ; Guan WB; Gu YP; Feng Y; Leng Y
Acta Pharmacol Sin; 2020 Nov; 41(11):1446-1456. PubMed ID: 32398684
[TBL] [Abstract][Full Text] [Related]
13. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
14. Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects.
Pedersen NB; Hjollund KR; Johnsen AH; Orskov C; Rosenkilde MM; Hartmann B; Holst JJ
Regul Pept; 2008 Feb; 146(1-3):310-20. PubMed ID: 18164496
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
16. Inosine reduces inflammation and improves survival in a murine model of colitis.
Mabley JG; Pacher P; Liaudet L; Soriano FG; Haskó G; Marton A; Szabo C; Salzman AL
Am J Physiol Gastrointest Liver Physiol; 2003 Jan; 284(1):G138-44. PubMed ID: 12388199
[TBL] [Abstract][Full Text] [Related]
17. The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis.
Ban H; Bamba S; Imaeda H; Inatomi O; Kobori A; Sasaki M; Tsujikawa T; Andoh A; Fujiyama Y
Oncol Rep; 2011 Jun; 25(6):1699-703. PubMed ID: 21431278
[TBL] [Abstract][Full Text] [Related]
18. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled receptor 40 activation ameliorates dextran sulfate sodium-induced colitis in mice via the upregulation of glucagon-likepeptide-2.
Kato S; Utsumi D; Matsumoto K
J Pharmacol Sci; 2019 Jun; 140(2):144-152. PubMed ID: 31242961
[TBL] [Abstract][Full Text] [Related]
20. PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice.
Lee S; Youn YS; Lee SH; Byun Y; Lee KC
Diabetologia; 2006 Jul; 49(7):1608-11. PubMed ID: 16586064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
